Rahul Banerjee: How do we standardize the standard of care for bortezomib (Velcade) in multiple myeloma?

Rahul Banarjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, recently wrote on his Twitter page:

“How do we standardize the standard of care for bortezomib (Velcade) in multiple myeloma?
Help us by filling out this 3-minute survey: https://redcap.link/velcade
So far >200 responses from 38 countries: many things we’ve learned about barriers to once-weekly V dosing!
Once-weekly or twice-weekly bortezomib in multiple myeloma: As bortezomib turns 20 years old, can we standardize the standard of care in terms of how it’s dosed? “

For details: Click here
Source: Rahul Banerjee / Twitter